Close Menu

NEW YORK ─ Siemens Healthineers said on Thursday that its SARS-CoV-2 total antibody test was the only one of four assays in a head-to-head study that met Target Product Profile (TPP)-sensitivity criteria for immunoassays established by the UK Medicines and Healthcare products Regulatory Agency.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.